Startseite/Aktien/PACB

PACB

USD

Pacific Biosciences of California Inc. Common Stock

$1.760+0.020 (1.149%)

Echtzeitkurs

Healthcare

Medizinprodukte

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.740

Hoch

$1.790

Tief

$1.630

Volumen

10.33M

Unternehmensfundamentaldaten

Marktkapitalisierung

531.4M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

8.24M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $0.85Aktuell $1.760Hoch $2.66

Ähnliche Nachrichten

10. Nov. 2025 · 14:16

Analyst Upgrades

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

Stephens & Co. analyst Mason Carrico maintains Pacific Biosciences with a Overweight and raises the price target from $1.8 to $2.

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

4. Nov. 2025 · 14:05

GlobeNewswire

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

22. Okt. 2025 · 20:05

GlobeNewswire

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5,